Genetic variability in the SNCA gene influences alpha-synuclein levels in the blood and brain
- PMID: 18162487
- DOI: 10.1096/fj.07-9348com
Genetic variability in the SNCA gene influences alpha-synuclein levels in the blood and brain
Abstract
Genetic variability in the promoter and 3' region of the SNCA gene coding alpha-synuclein modulates the risk to develop sporadic Parkinson's disease (PD). Whether this is mediated by regulating alpha-synuclein expression levels remains unknown. Therefore, we analyzed levels of alpha-synuclein in blood and human post mortem brain tissue including the substantia nigra using quantitative real-time reverse transcriptase-polymerase chain reaction and enzyme linked immunosorbent assay in vivo. Single nucleotide polymorphism (SNP) rs356219, a tagging SNP for a disease-associated haplotype in the 3' region of the SNCA gene, has a significant effect on SNCA mRNA levels in the substantia nigra and the cerebellum. Further, the "protective" genotype 259/259 of the PD-associated promoter repeat NACP-Rep1 is associated with lower protein levels in blood than genotypes 261/261, 259/261, and 259/263. In conclusion, we provide evidence that alpha-synuclein levels are influenced by genetic variability in the promoter and 3' region of the SNCA gene in vivo.
Similar articles
-
Levels of alpha-synuclein mRNA in sporadic Parkinson disease patients.Mov Disord. 2006 Oct;21(10):1703-8. doi: 10.1002/mds.21007. Mov Disord. 2006. PMID: 16795004
-
Cerebellar alpha-synuclein levels are decreased in Parkinson's disease and do not correlate with SNCA polymorphisms associated with disease in a Swedish material.FASEB J. 2008 Oct;22(10):3509-14. doi: 10.1096/fj.08-110148. Epub 2008 Jul 7. FASEB J. 2008. PMID: 18606870
-
alpha-Synuclein and Parkinson disease susceptibility.Neurology. 2007 Oct 30;69(18):1745-50. doi: 10.1212/01.wnl.0000275524.15125.f4. Epub 2007 Sep 13. Neurology. 2007. PMID: 17872362
-
[Relationship between alpha-synuclein and Parkinson's disease].Brain Nerve. 2007 Aug;59(8):825-30. Brain Nerve. 2007. PMID: 17713118 Review. Japanese.
-
[Neurodegeneration and epigenetics].Nihon Shinkei Seishin Yakurigaku Zasshi. 2012 Nov;32(5-6):269-73. Nihon Shinkei Seishin Yakurigaku Zasshi. 2012. PMID: 23373314 Review. Japanese.
Cited by
-
α-Synuclein in Parkinson's disease.Cold Spring Harb Perspect Med. 2012 Feb;2(2):a009399. doi: 10.1101/cshperspect.a009399. Cold Spring Harb Perspect Med. 2012. PMID: 22355802 Free PMC article. Review.
-
Age at onset in LRRK2-associated PD is modified by SNCA variants.J Mol Neurosci. 2012 Sep;48(1):245-7. doi: 10.1007/s12031-012-9820-7. Epub 2012 Jun 6. J Mol Neurosci. 2012. PMID: 22669510
-
α-Synuclein elevation in human neurodegenerative diseases: experimental, pathogenetic, and therapeutic implications.Mol Neurobiol. 2013 Apr;47(2):484-94. doi: 10.1007/s12035-012-8329-y. Epub 2012 Sep 4. Mol Neurobiol. 2013. PMID: 22944910 Review.
-
Long-term RNAi knockdown of α-synuclein in the adult rat substantia nigra without neurodegeneration.Neurobiol Dis. 2019 May;125:146-153. doi: 10.1016/j.nbd.2019.01.004. Epub 2019 Jan 15. Neurobiol Dis. 2019. PMID: 30658149 Free PMC article.
-
Genetic variability in SNCA and Parkinson's disease.Neurogenetics. 2011 Nov;12(4):283-93. doi: 10.1007/s10048-011-0292-7. Epub 2011 Jul 29. Neurogenetics. 2011. PMID: 21800132 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous